Keiretsu Capital
Private equity
Active
Seattle, United States
251
1M
131
14.76
2
0.48
12
- Stages of investment
- Areas of investment
Summary
Keiretsu Capital appeared to be the VC, which was created in 2007. The main department of described VC is located in the Seattle. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Keiretsu Capital, startups are often financed by Keiretsu Forum, Portland Seed Fund, Band of Angels. The meaningful sponsors for the fund in investment in the same round are Keiretsu Forum, Band of Angels, Sand Hill Angels. In the next rounds fund is usually obtained by Puget Sound Venture Club, Keiretsu Forum Northwest, Tech Coast Angels.
The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are SaaS, Internet. Among the most popular portfolio startups of the fund, we may highlight Transform, Inc., Alpin, Perkville. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2016. The fund is constantly included in 7-12 investment rounds annually. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations. When the investment is from Keiretsu Capital the average startup value is 5-10 millions dollars. This Keiretsu Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019.
The fund was created by Matthew Le Merle, Matthew Le Merle, Nathan McDonald, Randy Williams. We also calculated 12 valuable employees in our database.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 251
- Lead investments
- 2
- Exits
- 12
- Rounds per year
- 14.76
- Follow on index
- 0.48
- Investments by industry
- Health Care (86)
- Biotechnology (63)
- Medical (49)
- Medical Device (45)
- Software (42) Show 170 more
- Investments by region
-
- United States (231)
- India (2)
- Canada (12)
- Israel (2)
- Turkey (1) Show 2 more
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 13M
- Group Appearance index
- 0.34
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.25
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Atrin Pharmaceuticals | 02 Jul 2022 | Biotechnology, Medical, Pharmaceutical, Therapeutics, Content Discovery | Early Stage Venture | United States, Pennsylvania | |
Clensta | 10 Jul 2023 | Biotechnology, Health Care, Wellness | Early Stage Venture | 9M | Delhi, New Delhi, India |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.